New York State Common Retirement Fund Nuvation Bio Inc. Transaction History

New York State Common Retirement Fund

$73.9 Billion
Q3 2024

A detailed history of New York State Common Retirement Fund transactions in Nuvation Bio Inc. stock. As of the latest transaction made, New York State Common Retirement Fund holds 48,128 shares of NUVB stock, worth $135,720. This represents 0.0% of its overall portfolio holdings.

Number of Shares

48,128

Previous 48,128 -0.0%

Holding current value

$135,720

Previous $141,000 21.99%

% of portfolio

0.0%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 31, 2024	BUY	$2.58 - $3.69 $384 - $549	149 Added 0.31%	48,128 $141,000
Q1 2024 May 07, 2024	SELL	$1.46 - $3.97 $281 - $766	-193 Reduced 0.4%	47,979 $175,000
Q4 2023 Feb 01, 2024	SELL	$0.96 - $1.53 $273 - $436	-285 Reduced 0.59%	48,172 $73,000
Q3 2023 Nov 07, 2023	BUY	$1.26 - $2.1 $842 - $1,404	669 Added 1.4%	48,457 $65,000
Q2 2023 Aug 07, 2023	SELL	$1.56 - $1.84 $198 - $233	-127 Reduced 0.27%	47,788 $86,000
Q1 2023 May 02, 2023	SELL	$1.6 - $2.48 $55,040 - $85,312	-34,400 Reduced 41.79%	47,915 $80,000
Q4 2022 Jan 30, 2023	SELL	$1.68 - $2.5 $294 - $437	-175 Reduced 0.21%	82,315 $158,000
Q3 2022 Nov 08, 2022	BUY	$0.29 - $4.04 $21 - $303	75 Added 0.09%	82,490 $185,000
Q2 2022 Aug 04, 2022	SELL	$3.24 - $5.85 $59,091 - $106,692	-18,238 Reduced 18.12%	82,415 $267,000
Q1 2022 May 05, 2022	BUY	$4.6 - $8.83 $80,615 - $154,745	17,525 Added 21.08%	100,653 $529,000
Q4 2021 Feb 02, 2022	BUY	$7.75 - $10.05 $338,341 - $438,752	43,657 Added 110.61%	83,128 $707,000
Q3 2021 Nov 02, 2021	BUY	$7.78 - $10.0 $71,350 - $91,710	9,171 Added 30.27%	39,471 $392,000
Q2 2021 Aug 02, 2021	BUY	$9.22 - $14.48 $279,366 - $438,744	30,300 New	30,300 $282,000

Others Institutions Holding NUVB

# of Institutions

158

Shares Held

157M

Call Options Held

3.2K

Put Options Held

98.7K

View Full List

About Nuvation Bio Inc.

Ticker NUVB
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 217,244,000
Market Cap $613M
Description
Nuvation Bio Inc., a clinical-stage biopharmaceutical company, focuses on the development of therapeutic candidates for oncology. The company's lead product candidate is NUV-422, a small molecule inhibitor targeting cyclin-dependent kinase (CDK)2, CDK4, and CDK6. It is also developing NUV-868, a selective oral small molecule BET inhibitor that e...

More about NUVB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of New York State Common Retirement Fund, based on Form 13F filings with the SEC.

News

Stay updated on New York State Common Retirement Fund with notifications on news.

Account

New York State Common Retirement Fund Nuvation Bio Inc. Transaction History